Healthcare teams should treat periodic pentesting as one input, not the control surface. A stronger model combines continuous testing, bug bounty programs, and hybrid pentesting to find weaknesses between assessments. That approach helps organisations detect issues sooner, prioritise remediation by impact, and reduce the chance that exploitable gaps persist long enough to affect patient data or care delivery.
Why This Matters for Security Teams
Clinical environments are difficult to secure because the same systems that store sensitive data also support care delivery, imaging, prescribing, lab workflows, and third-party access. Periodic pentesting can validate a point in time, but it rarely reflects how exposure changes after patching, configuration drift, new integrations, or emergency access changes. Security teams need a broader view that ties testing to operational risk, not just audit evidence. The NIST Cybersecurity Framework 2.0 is useful here because it treats risk management as an ongoing function rather than a one-off exercise.
That matters in healthcare because attackers do not wait for the next assessment window. They exploit stale VPN access, exposed remote services, weak segmentation, and forgotten assets that sit outside the scope of a scheduled test. When clinical uptime is the priority, remediation often gets deferred unless teams can prove practical impact on patient data, workflow integrity, or availability. The real goal is to shorten the time between weakness introduction, detection, and correction.
In practice, many security teams encounter those gaps only after a ransomware event or a delayed incident review has already shown how long the exposure was present.
How It Works in Practice
Moving beyond periodic pentesting means building a testing and validation cycle that reflects the pace of change in the environment. Hybrid pentesting combines traditional human assessment with automated scanning, attack-path analysis, and continuous validation of critical control points. Bug bounty programs can add external perspective, especially for internet-facing portals and patient-facing services, while internal purple-team exercises help confirm whether detections and containment steps work under realistic conditions. The point is not to replace pentesting, but to make it part of a larger assurance model.
For healthcare, the strongest programs usually focus on assets and workflows that create the highest clinical or regulatory impact: electronic health records, identity providers, remote access gateways, medical device management platforms, and integration engines. Security teams should map findings to business process and patient safety, then feed those results into remediation queues that are tracked like operational risks. Guidance in NIST SP 800-53 Rev 5 Security and Privacy Controls supports this approach by tying technical testing to control validation and continuous monitoring.
- Run continuous discovery to identify new internet-facing services, cloud exposures, and unmanaged assets.
- Prioritise tests around privileged paths, clinical downtime dependencies, and externally reachable attack surfaces.
- Use bug bounty or coordinated disclosure for the systems most likely to be probed first by real attackers.
- Validate whether detections, segmentation, and response playbooks actually work after each major change.
- Track remediation by patient impact and service dependency, not only by CVSS score.
Healthcare teams should also treat AI-enabled adversary tradecraft as part of the threat model, because automation is lowering the effort needed for reconnaissance and social engineering, as highlighted in the Anthropic report on the first AI-orchestrated cyber espionage campaign. These controls tend to break down when asset inventories are incomplete and clinical owners cannot interrupt live systems long enough to test or remediate them.
Common Variations and Edge Cases
Tighter continuous testing often increases operational overhead, requiring organisations to balance faster risk reduction against change-management friction and service stability. That tradeoff is especially visible in clinical environments with legacy medical devices, outsourced hosting, or limited maintenance windows. Best practice is evolving here: there is no universal standard for how often every system should be retested, so teams should set testing frequency by exposure level, business criticality, and observed change rate.
Edge cases matter. Air-gapped or semi-isolated environments may still need attack-path reviews because removable media, vendor laptops, and shared administration accounts create indirect entry points. Cloud-hosted healthcare applications often need more frequent validation than on-premise systems because infrastructure and identity posture can change rapidly. For regulated environments, continuous testing also needs clear rules about evidence handling, patient data exposure, and vendor participation so that assurance activity does not itself create compliance risk. Where teams rely on bug bounty programs, scope discipline and safe-harbour language are essential to avoid ambiguity around production systems.
The practical decision is not whether to keep pentesting, but how to combine it with continuous validation, response testing, and ownership for remediation so weaknesses do not persist across clinical cycles.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
MITRE ATT&CK address the attack and risk surface, while NIST CSF 2.0, NIST AI RMF and NIST SP 800-53 Rev 5 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | GV.OC-01 | Clinical risk needs ongoing oversight, not just point-in-time tests. |
| NIST AI RMF | AI-assisted attacker tradecraft raises the need for adaptive assurance. | |
| NIST SP 800-53 Rev 5 | CA-7 | Continuous monitoring underpins validation beyond periodic pentesting. |
| MITRE ATT&CK | T1190 | External exploitation remains a primary risk to clinical-facing systems. |
Set continuous testing as a governed risk activity with clear business ownership and review cadence.
Related resources from NHI Mgmt Group
- How should security teams reduce risk from secrets in CI environments?
- How should NHS security teams reduce privileged access risk without disrupting clinical operations?
- How can security teams reduce the risk of session hijacking in SaaS environments?
- How should security teams reduce refresh token risk in SaaS environments?
